Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Schmid

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Public Health|June 1, 1991
Condom use during pregnancyB C Schmid, E S Sharp, R A Hatcher, et al.
Cancer Letters|October 26, 1999
Expression of mucins and cytokeratins in ovarian cancer cell linesM Stimpfl, B C Schmid, I Schiebel, et al.
Oncology Research|May 10, 2000
Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral bloodM Stimpfl, B C Schmid, A Obermair, et al.
Gynecologic Oncology|October 19, 2001
Novel MUC1 splice variants are expressed in cervical carcinomaA Obermair, B C Schmid, M Stimpfl, et al.
British Journal of Cancer|January 25, 2007
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathwayD Pils, A Pinter, J Reibenwein, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Public Health|June 1, 1991
Condom use during pregnancyB C Schmid, E S Sharp, R A Hatcher, et al.
Cancer Letters|October 26, 1999
Expression of mucins and cytokeratins in ovarian cancer cell linesM Stimpfl, B C Schmid, I Schiebel, et al.
Oncology Research|May 10, 2000
Comparison of flow cytometry and RT-PCR for the detection of ovarian cancer cells in peripheral bloodM Stimpfl, B C Schmid, A Obermair, et al.
Gynecologic Oncology|October 19, 2001
Novel MUC1 splice variants are expressed in cervical carcinomaA Obermair, B C Schmid, M Stimpfl, et al.
British Journal of Cancer|January 25, 2007
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathwayD Pils, A Pinter, J Reibenwein, et al.
Pageof 1